CompuCyte licenses test for rapid sepsis diagnosis
This article was originally published in Clinica
Executive Summary
CompuCyte has licensed a rapid point-of-care assay for detecting neonatal sepsis from Stanford University. The test could lead to considerable savings in unnecessary hospitalisation and treatment costs.